Etodolac 400 mg / Cyclobenzaprine 10 mg fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Etodolac 400 mg / Cyclobenzaprine 10 mg fixed-dose combination, covering 2023-02-09 to 2023-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction [Phase 3]